Taikang Asset Management (Hong Kong) CO LTD Vir Biotechnology, Inc. Transaction History

Taikang Asset Management (Hong Kong) CO LTD

  • $641 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022
SELL
$19.08 - $26.7 $10.2 Million - $14.2 Million
-533,332 Closed
0 $0
Q1 2021

May 14, 2021
SELL
$26.34 - $83.07 $2.34 Million - $7.38 Million
-88,889 Reduced 14.29%
533,332 $27.3 Million
Q2 2020

Aug 12, 2020
BUY
$27.89 - $47.86 $17.4 Million - $29.8 Million
622,221 New
622,221 $25.5 Million

Others Institutions Holding VIR

# of Institutions
223
Shares Held
86.1M
Call Options Held
231K
Put Options Held
132K
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $1.28B
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Taikang Asset Management (Hong Kong) CO LTD Portfolio

Follow Taikang Asset Management (Hong Kong) CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Taikang Asset Management (Hong Kong) CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Taikang Asset Management (Hong Kong) CO LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email